The deal adds early-stage candidates for breast, lung, and other tumour types, using RIPTAC technology, to J&J’s pipeline.

Johnson & Johnson (NYSE: JNJ) (the "Company") today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. ("Halda"), a clinical-stage biotechnology company with a ...

Johnson & Johnson has announced the successful completion of its acquisition of Halda Therapeutics OpCo, a clinical-stage ...

Johnson & Johnson completes acquisition of clinical-stage biotechnology company, Halda Therapeutics: New Brunswick, New Jersey Wednesday, December 31, 2025, 12:00 Hrs [IST] Johnso ...

A tiny spider frozen in 100-million-year-old amber is changing what scientists thought they knew about spider evolution. This ...

There are two views of India globally. The first sees India as a future superpower, forming the third pole in an ...

Scientists have utilised revolutionary DNA base editing to treat previously incurable T-cell acute lymphoblastic leukaemia.

One of the main issues has been the over-bureaucratising nature of regulation in Indian higher academia, which is still a predominantly elite savarna enclave, especially in its higher tiers, despite ...

Acquisition brings an advanced, highly differentiated treatment for prostate cancer, strengthening Johnson & Johnson's longstanding commitment to innovation in the disease Lead asset demonstrates pote ...

Today when people talk about the movement, they think first of visual artists, especially Salvador Dalí. and René Magritte.

Genmab A/S announced today that it will discontinue further clinical development of acasunlimab. This decision was made as part of Genmab's strategic focus on the most value?creating opportunities in ...

As the tractors roll back into the streets of Brussels and London, it feels an opportune moment to reflect on the state of ...